FDA label
What is Renvela used for?
Renvela contains sevelamer carbonate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Renvela ®(sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Renvela?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Renvela, powder, for suspension
Indications and Usage, quoted from the label by Genzyme Corporation (NDA022318). Cross-references to other label sections are left out.
Renvela ®(sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
Source: DailyMed label, set id e6328460-a57b-450b-a48c-6dcd4b476360, version 47, effective November 25, 2025. NDC 58468-0131, one of 2 listings for this product.
Questions
What is Renvela used for?
The FDA label says: “Renvela ®(sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.”
What drug class is Renvela?
FDA lists sevelamer carbonate in the Phosphate Binder established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Renvela
- Is Renvela a controlled substance?Federal schedule
- Generic for RenvelaFDA Orange Book
- What is Sevelamer Carbonate used for?FDA label uses
- Is Sevelamer Carbonate a controlled substance?Federal schedule
- Phosphate Binders listFDA drug class
- NDC 58468-0131Renvela NDC record
- NDC 58468-0132Renvela NDC record
- NDC 58468-0133Renvela NDC record